Slowdown in acute gastro portfolio
Domestic growth was impacted by slowdown in acute gastro portfolio, which could persist and drag overall domestic growth.
JBCHEPHARM / bear-case history
Track the concerns that keep returning.
JB Chemicals & Pharmaceuticals · risk themes across the available quarters.
Research layer active
Bear-case history
Risks carried through the record.
medium
Merger with Torrent delayed or not completed
Merger closure expected in Q4 FY26, but management was evasive on timeline and synergies, indicating potential delays.
High base effect in CDMO business
CDMO segment remained flat due to high base in Q3 FY25; growth may be lumpy going forward.